PROTEIN-PHOSPHORYLATION IN THE REGULATION OF INSULIN-SECRETION - THE USE OF SITE-DIRECTED INHIBITORY PEPTIDES IN ELECTRICALLY PERMEABILIZEDISLETS OF LANGERHANS
H. Basudev et al., PROTEIN-PHOSPHORYLATION IN THE REGULATION OF INSULIN-SECRETION - THE USE OF SITE-DIRECTED INHIBITORY PEPTIDES IN ELECTRICALLY PERMEABILIZEDISLETS OF LANGERHANS, Acta diabetologica, 32(1), 1995, pp. 32-37
We have used electrically permeabilised rat islets of Langerhans to in
vestigate the role of protein phosphorylation in the regulation of ins
ulin secretion using pseudosubstrate inhibitory peptides for cyclic AM
P-dependent protein kinase (PKA) and for protein kinase C (PKC). The p
rotein kinase inhibitor (PKI) peptide, PKI(6-22), completely inhibited
the effects of cyclic AMP on islet PKA activity in vitro, on endogeno
us protein phosphorylation and on insulin secretion. This peptide had
no significant effect on islet PKC activity in vitro, on Ca2+-induced
protein phosphorylation and on secretory responses to Ca2+ or to the P
KC activator, 4 beta-phorbol myristate acetate (PMA). The PKC pseudo-s
ubstrate inhibitory peptide, PKC(19-36), caused a marked inhibition of
islet PKC activity in vitro and inhibite PMA-induced insulin secretio
n without affecting secretory responses to cyclic AMP and Ca2+. These
results demonstrate that PKA- and PKC-induced protein phosphorylation
is obligatory for cyclic AMP- and PMA-stimulated insulin secretion, re
spectively, and suggest that there is little ''crosstalk'' between the
response elements of the secretory pathways to the different second m
essengers, at least after the generation of the messengers within the
beta-cells.